These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15584983)

  • 1. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice.
    Yakovleva O; Janiak A; McKenzie C; McShane L; Brown P; Cervenakova L
    Transfusion; 2004 Dec; 44(12):1700-5. PubMed ID: 15584983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
    Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
    Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
    Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
    Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt-Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry.
    Fagge T; Barclay GR; Macgregor I; Head M; Ironside J; Turner M
    Transfusion; 2005 Apr; 45(4):504-13. PubMed ID: 15819670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy.
    Cervenakova L; Yakovleva O; McKenzie C; Kolchinsky S; McShane L; Drohan WN; Brown P
    Transfusion; 2003 Dec; 43(12):1687-94. PubMed ID: 14641865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of removal of prion infectivity from red blood cells with prion reduction filters using a new rapid and highly sensitive cell culture-based infectivity assay.
    Sowemimo-Coker SO; Demczyk CA; Andrade F; Baker CA
    Transfusion; 2010 May; 50(5):980-8. PubMed ID: 20003057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets.
    Cooper JK; Ladhani K; Minor P
    Vox Sang; 2012 Feb; 102(2):100-9. PubMed ID: 22126309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-resistant prion protein in lymphoreticular tumors of variant Creutzfeldt-Jakob disease mice.
    Cervenakova L; Yakovleva O; McKenzie C
    Emerg Infect Dis; 2006 Mar; 12(3):511-3. PubMed ID: 16704797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental transmission of two young and one suspended bovine spongiform encephalopathy (BSE) cases to bovinized transgenic mice.
    Yokoyama T; Masujin K; Yamakawa Y; Sata T; Murayama Y; Shu Y; Okada H; Mohri S; Shinagawa M
    Jpn J Infect Dis; 2007 Sep; 60(5):317-20. PubMed ID: 17881878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
    Thackray AM; Hopkins L; Bujdoso R
    Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partitioning of TSE infectivity during ethanol fractionation of human plasma.
    Gregori L; Maring JA; MacAuley C; Dunston B; Rentsch M; Kempf C; Rohwer RG
    Biologicals; 2004 Mar; 32(1):1-10. PubMed ID: 15026020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP(Sc).
    Gao JM; Zhou XB; Xiao XL; Zhang J; Chen L; Gao C; Zhang BY; Dong XP
    Acta Virol; 2006; 50(1):25-32. PubMed ID: 16599182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSE clearance during plasma products separation process by Gradiflow(TM).
    Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
    Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.
    Collins SJ; Lewis V; Brazier MW; Hill AF; Lawson VA; Klug GM; Masters CL
    Neurobiol Dis; 2005 Nov; 20(2):336-46. PubMed ID: 16242640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a proteinase K-sensitive PrPSc fraction.
    Pastrana MA; Sajnani G; Onisko B; Castilla J; Morales R; Soto C; Requena JR
    Biochemistry; 2006 Dec; 45(51):15710-7. PubMed ID: 17176093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.